OABI Q3 2025 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-46.3% YoY

Gross Profit

-$2M-109.2% margin

Operating Income

-$18M-811.3% margin

Net Income

-$17M-738.1% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-42.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$310M

Total Liabilities

$32M

Stockholders' Equity

$277M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-46.3%
Gross Profit	-$2M	$4M	-158.6%
Operating Income	-$18M	-$20M	+8.1%
Net Income	-$17M	-$16M	-0.9%

Revenue Segments

Service

$1M77%

Royalty

$361,00023%